Searchable abstracts of presentations at key conferences in endocrinology

ea0035p464 | Diabetes therapy | ECE2014

The outcome of β cell function after early insulin therapy in the recently diagosed type 2 diabetes (in Egyptian population) our experience in EL-Minia university hospital

Kamel Mesbah , mousa Youssef , Eldeen Ahmed saad , Mohamed Ahmed , Elhini Sahar , Elsagheer Ghada , Osman Ashraf

Background: Worsening hyperglycemia in type 2 diabetes may be due to continuous decline in insulin secretion secondary to β-cell dysfunction and decreased insulin sensitivity. The purpose of this prospective cohort study was to evaluate whether early insulin therapy is more advantageous in achieving long-term optimal glycemic control with improved B cell function than oral drugs in the recently diagnosed type 2 diabetes mellitus.Methods: Sixty conse...

ea0037ep494 | Diabetes (complications & therapy) | ECE2015

Angiopoietin 1 in patients with type 2 diabetes mellitus and diabetic retinopathy

El Sattar El-Deeb Abd , Halawa Mohamed , Saad Ahmed , Sabry Inas , Mahdy Maram , Abd El Aziz Mohamed , Roshdy Nagwa

Background: Diabetic retinopathy (DR) is a clinically well-defined sight-threatening complication in type 2 diabetes. Angiopoietin 1 (Ang1) has been shown to promote endothelial cell survival without causing proliferation, stabilise endothelial interactions with surrounding support cells and can block the vascular permeability effects of vascular endothelial growth factor (VEGF). More recent data suggest that balance between these growth factors may affect vascular endothelial...